Benzinga | Nov 5, 2020 06:54AM EST

ANI Pharmaceuticals Q3 Adj. EPS $0.97 Beats $0.88 Estimate, Sales $53.00M Beat $51.50M Estimate

ANI Pharmaceuticals (NASDAQ:ANIP) reported quarterly earnings of $0.97 per share which beat the analyst consensus estimate of $0.88 by 10.23 percent. This is a 21.14 percent decrease over earnings of $1.23 per share from the same period last year. The company reported quarterly sales of $53.00 million which beat the analyst consensus estimate of $51.50 million by 2.91 percent. This is a 3.24 percent increase over sales of $51.34 million the same period last year.